Authorization

DGAP-News: Eckert & Ziegler delivers a record result

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Annual Results/Forecast


Eckert & Ziegler delivers a record result


05.04.2019 / 07:45



The issuer is solely responsible for the content of this announcement.


Berlin, 05 April 2019. In 2018, the Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope technology applications in medicine, science and industry, generated sales of EUR 168.7 million (previous year: EUR 138.6 million based on continuing operations) and thus clearly surpassing its previous record sales in 2017. Consolidated net income also reached a new high of EUR 16.1 million (previous year: EUR 14.7 million) translating into earnings per share of EUR 3.12.

The strong euro had an adverse effect on foreign currency sales and sales growth in all segments, costing the Group EUR 4.4 million in sales compared to the previous year. On a currency-adjusted basis, sales would have increased by EUR 34.5 million or 25%. Organic, real sales growth, i.e. sales adjusted for currency effects and acquisitions and disposals made in 2017 and 2018, amounted to EUR 25.6 million or 18%.

The Isotope Products segment posted the largest increase in sales based on continuing operations, increasing its sales by EUR 22.6 million or 25% to EUR 112.3 million due to the consolidation of the Gamma-Service Group acquired at the end of May 2017 and the strong demand in the energy sector.

Sales in the Radiation Therapy segment increased by EUR 4.7 million or 18% to EUR 30.6 million, driven by solid sales generated by HDR tumour irradiation systems and WOMED acquired in January 2018.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Июль 2019    »
ПнВтСрЧтПтСбВс
1234567
891011121314
15161718192021
22232425262728
293031